The unreversible reduced but persistent activated NK and CD8 <sup>+</sup> T cells in severe/critical COVID-19 during omicron pandemic in China-Reference-Cited by-全球学者库

The unreversible reduced but persistent activated NK and CD8 ⁺ T cells in severe/critical COVID-19 during omicron pandemic in China

Published:2023-05-15 Issue:1 Volume:12 Page:
ISSN:2222-1751
Container-title:Emerging Microbes & Infections
language:en
Short-container-title:Emerging Microbes & Infections

Author:

Qin Ling¹,Duan Xinmin¹²,Dong Jay Zengjun³,Chang Yue¹,Han Yang¹,Li Yan⁴⁵,Jiang Wei⁶,Fan Hongwei¹,Hou Xiufeng¹,Cao Wei¹,Zhu Huadong⁴⁵,Li Taisheng¹⁵⁷

Affiliation:

1. Department of Infectious Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, People’s Republic of China

2. School of Clinical Medicine, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, People’s Republic of China

3. KP Medical Partners Ltd, Taizhou, People's Republic of China

4. Emergency Department, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, People’s Republic of China

5. State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, People’s Republic of China

6. Medical Intensive Care Unit, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, People’s Republic of China

7. Tsinghua University Medical College, Beijing, People’s Republic of China

Funder

Key Clinical Specialties Program of Beijing, China

Scientific and Technical Innovation in Medical and Health Project of the Chinese Academy of Medical Science

Special Research Fund for the Central High-level Hospitals of Peking Union Medical College Hospital

PUMCH

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Drug Discovery,General Medicine,Immunology,Microbiology,Parasitology,Epidemiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/22221751.2023.2208679

Reference23 articles.

1. Estimating the transmission dynamics of SARS-CoV-2 Omicron BF.7 in Beijing after adjustment of the zero-COVID policy in November–December 2022

2. Hypothesis for potential pathogenesis of SARS-CoV-2 infection–a review of immune changes in patients with viral pneumonia

3. Clinical characteristics and analysis of risk factors for disease progression of patients with SARS-CoV-2 Omicron variant infection: A retrospective study of 25207 cases in a Fangcang hospital

4. Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China

5. Biomarkers for Prognosis and Treatment Response in COVID-19 Patients